Clinical Implications of MicroRNAs in Lung Cancer
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 38 (6) , 776-780
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung CarcinomaCancer Research, 2010
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markersInternational Journal of Cancer, 2010
- Altered miRNA expression in sputum for diagnosis of non-small cell lung cancerLung Cancer, 2010
- MicroRNA Expression Differentiates Histology and Predicts Survival of Lung CancerClinical Cancer Research, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokersProceedings of the National Academy of Sciences, 2009
- Exosomal MicroRNA: A Diagnostic Marker for Lung CancerClinical Lung Cancer, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008